BioSpace News Archive

Policy

New drug for mild and moderate Alzheimer’s approved in China

Shanghai Green Valley Pharmaceuticals announced that China’s National Medical Products Administration has approved Oligomannate as new drug for the treatment of mild to moderate Alzheimer’s disease.

November 5, 2019
·
1 min read
BASF to present three new digital solutions for the pharma industry during CPhI 2019

Leveraging the concept of virtual assistants, BASF expertise becomes available to its customers, supporting during all stages of the drug development process

November 5, 2019
·
3 min read
Genetown

Shimmer Receives CE Certification for its ECGmd Holter Monitor Electrocardiograph

ECGmd is now recognized as a medical device in Europe, capable of providing medical-grade ECG output from Shimmer’s wearable sensor

November 5, 2019
·
2 min read
Business

Taking Better Aim at Nasopharyngeal Carcinoma Using Proton Therapy

A*STAR’s Institute of Bioengineering and Nanotechnology has teamed up with the Singapore Institute of Advanced Medicine Holdings Pte Ltd to explore how to better tackle nasopharyngeal carcinoma, a type of head and neck cancer, through targeted proton therapy.

November 5, 2019
·
5 min read
SciRhom Initiates First-In-Class Antibody Development Program to Treat Major Autoimmune Diseases

Bench to bedside research provides a new business opportunity: Newly discovered antibodies against iRhom2 block several pro-inflammatory pathways simultaneously, promising significant improvement over current autoimmune therapies.

November 5, 2019
·
9 min read
Imactis secures first US customer with UW Health acquiring cutting-edge navigation system to facilitate image-guided interventional oncology procedures

First hospital in US to acquire French medtech firm’s CT-Navigation™ system to increase accuracy in radiology procedures, while decreasing treatment times and radiation exposure of patients and healthcare professionals

November 5, 2019
·
3 min read
Eveliqure’s effort to develop a Shigella-ETEC combination vaccine for travelers and children in resource poor countries is supported by the Wellcome Trust

Eveliqure Biotechnologies announces the grant of a Wellcome Trust Innovator Award that supports the early clinical development of its Shigella-ETEC combination vaccine with ~£500K and complements the previously secured ~€11 million funding from public sources for the vaccine’s development

November 5, 2019
·
2 min read
Business

Montefiore Medicine Names Philip O. Ozuah, MD, PhD, As CEO

Montefiore Medicine’s Board of Trustees announced today that Dr. Philip O. Ozuah has been named the next Chief Executive Officer of Montefiore Medicine, the umbrella organization for Montefiore Health System (MHS) and Albert Einstein College of Medicine

November 5, 2019
·
5 min read
Business

Inogen Announces Third Quarter 2019 Financial Results

Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, reported financial results for the three-month period ended September 30, 2019.

November 5, 2019
·
19 min read
Business

American Renal Associates Holdings, Inc. Announces Third Quarter 2019 Results

American Renal Associates Holdings, Inc., a leading kidney care and dialysis provider focused on partnering with local nephrologists, announced financial and operating results for the third quarter ended September 30, 2019.

November 5, 2019
·
35 min read